
|Articles|January 30, 2014
The Future of ePRO Platforms
Author(s)Guest Blogger
It is tempting to imagine the use of the patient’s own mobile computing platform for collection of patient reported outcomes.
Advertisement
It is tempting to imagine the use of the patient’s own mobile computing platform for collection of patient reported outcomes. This would solve some of the problems faced when using the e-PRO devices employed today:
- Provisioning costs (purchasing or leasing the devices to be used in the trial)
- Supply issues (delivering the devices to the sites for distribution to subjects, and collection after the subject completes the trial)
- Training (handling and use of the device by subjects and site staff)
- Maintenance and Help Desk (device-related help desk questions, replacement of faulty devices)
Click
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026: Novavax Shifting Towards Partnership-Driven Strategy
2
What is Daiichi Sankyo’s Strategy for Preparing for the JP Morgan Healthcare Conference?
3
Novartis Calls for Global Governments to Address Global Trade Policy
4
JP Morgan 2026: Regeneron Focusing on Broad Pipeline Development
5




